JP TSE 4527 Pharmaceutical

Rohto Pharmaceutical Co., Ltd.

ロート製薬株式会社

Revenue

¥344B

≈ $2.2B

Net income

¥34.2B

≈ $217.0M

Income taxes paid

¥11.9B

≈ $75.7M

Total assets

¥486B

≈ $3.1B

Equity ratio

65.9%

Ranked #341 among listed Japanese companies by corporate taxes paid · effective tax rate 26.5%.

Share price at fiscal year-end: ¥2,410 · market capitalization ¥569B · P/E 15.9 · P/B 1.78

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥344B	¥34.2B	¥12.4B	¥11.9B	¥486B	¥320B	65.9%	EDINET (consol.)
Mar 2025	¥309B	¥30.8B	¥11.2B	¥11.2B	¥437B	¥281B	64.2%	EDINET (consol.)
Mar 2024	¥271B	¥30.9B	—	—	¥346B	¥247B	71.4%	EDINET (consol.)
Mar 2023	¥239B	¥26.4B	—	—	¥310B	¥215B	69.5%	EDINET (consol.)
Mar 2022	¥200B	¥21.1B	—	—	¥275B	¥184B	66.9%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.